Kabeer Aziz
InvestorPartner at Adjuvant Capital
New York, New York
Writes $100K β $5M checks Β· typically $1.5M
About
Kabeer Aziz is co-founder and partner at Adjuvant Capital. He previously worked at the Global Health Investment Fund, where he managed investments including Themis, Univercells, Atomo Diagnostics, and Access Bio, and earlier held roles at Metalmark Capital investing in healthcare and at Greenhill & Co. advising on biopharmaceutical M&A. He holds a degree from the Stern School of Business at New York University.
ContactΒ· self-published, not guessed
Invests in
BiotechHealthtech
Experience
- Adjuvant CapitalPartnercurrent2018 β presentNew York, NY
- AN2 TherapeuticsDirectorcurrent2019 β presentCalifornia, United States
- Minervax ApSDirectorcurrent2020 β presentDenmark
- PulmocideDirectorcurrent2021 β presentUnited Kingdom
- Curevo VaccineBoard Observercurrent2022 β presentWashington, United States
- Frontier Nutrition, Inc.Director2020 β 2026Bangladesh
- ChromaCode, Inc.Director2024 β 2026California, United States
- LimmaTech Biologics AGDirector2023 β 2024Switzerland
- Quantoom BiosciencesDirector2021 β 2023Belgium
- Themis Bioscience GmbHBoard Observer2018 β 2020Austria
- Global Health Investment FundSenior Associate2015 β 2018New York, NY
- Metalmark CapitalAssociate2013 β 2015New York, NY
- Greenhill & Co.Analyst2010 β 2013New York, NY
Investments
Led
Access BioAtomo DiagnosticsThemisUnivercells
Board seats
AN2 TherapeuticsMinervaXUnivercells VaccinesYisheng Biopharma
Per the firm's website.
Colleagues at Adjuvant Capital
Abrar Haque
Associate at Adjuvant Capital
Alexandra (Sandra) Glucksmann
Advisory Partner at Adjuvant Capital
Christian Mandl
Senior Advisor at Adjuvant Capital
Curt LaBelle
Venture Partner at Adjuvant Capital
David Washer
Investor at Adjuvant Capital
Evelyn Yanatos
Director of Finance and Compliance at Adjuvant Capital
Gerard Cunningham
Operating Partner at Adjuvant Capital
Giulia Balconi
Associate at Adjuvant Capital
Network1
Investors connected to Kabeer in public investor directories β a warm-intro map.
Frequently asked questions
- Who is Kabeer Aziz?
- Kabeer Aziz is co-founder and partner at Adjuvant Capital. He previously worked at the Global Health Investment Fund, where he managed investments including Themis, Univercells, Atomo Diagnostics, and Access Bio, and earlier held roles at Metalmark Capital investing in healthcare and at Greenhill & Co. advising on biopharmaceutical M&A. He holds a degree from the Stern School of Business at New York University.
- Where does Kabeer Aziz work?
- Kabeer Aziz is Partner at Adjuvant Capital.
- What does Kabeer Aziz invest in?
- Kabeer Aziz invests in Biotech, Healthtech.
- What check size does Kabeer Aziz write?
- Kabeer Aziz typically writes checks of $100K β $5M.
- What boards does Kabeer Aziz sit on?
- Kabeer Aziz holds tracked board seats at AN2 Therapeutics, MinervaX, Univercells Vaccines, Yisheng Biopharma.
- What companies has Kabeer Aziz invested in?
- Investments tracked here include Access Bio, Atomo Diagnostics, Themis, Univercells.
- Where did Kabeer Aziz go to school?
- Kabeer Aziz studied at NYU Stern School of Business (B.S., Finance & Economics).
- Does Kabeer Aziz lead rounds?
- Yes β Kabeer Aziz has led 4 tracked investments.
Same school
Also attended NYU Stern School of Business430
Luna SchmidInvestor at GV (Google Ventures)Kaz TeradaVenture Advisor at Monta Vista CapitalNeil FongManaging Director Asia at Burda Principal InvestmentsAlex TosoliniAdvisor at CincyTechMax WechterSenior Director of AI at Lerer HippeauKrupa VankayalaPartner, People & HR at Sapphire Ventures
+ 424 more
